Hospital
MT Grant General Hospital
MT Grant General Hospital was paid $1.02M by Medicaid between Jan 2018 and Dec 2024, across 69 billing codes. Its largest line is 99285, emergency room visit (most serious) — 22% of everything it billed.
33Billing provider infoMT GRANT GENERAL HOSPITAL
HAWTHORNE, NV 89415
HAWTHORNE, NV 89415
33aNPI1801844527assigned 05/05/2006
33bProvider typeCritical Access Hospital
28Total paid$1.02M
24GClaims69,895
24DCodes billed69
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Nevada
Rank by total paid#4 of 9
Median peer was paid$955K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,452 | $34K | |
| 2019 | 10,986 | $44K | |
| 2020 | 10,284 | $39K | |
| 2021 | 14,461 | $95K | |
| 2022 | 11,030 | $108K | |
| 2023 | 8,238 | $95K | |
| 2024incomplete | 6,444 | $602K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 758 | 513 | $219K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 2,689 | 1,807 | $199K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 1,274 | 845 | $131K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 12% | 2,078 | 405 | $122K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 10% | 2,768 | 2,076 | $107K |
| 80053 | Comprehensive metabolic panel | 6.9% | 7,908 | 5,451 | $70K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.1% | 3,209 | 1,610 | $42K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.6% | 1,125 | 913 | $16K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 409 | 321 | $13K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 735 | 470 | $12K |
| 80061 | Lipid panel | 1.1% | 1,984 | 1,729 | $11K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 131 | 72 | $10K |
57 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 96 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,629 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,192 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 481 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 879 | $4K |
| 80305 | <1% | 504 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 34 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 100 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,510 | $3K |
| 86769 | <1% | 326 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,016 | $3K |
| 80050 | General health panel | <1% | 79 | $2K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 15 | $2K |
| 71250 | <1% | 20 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,285 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,193 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 628 | $980.65 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 451 | $813.14 |
| 84484 | <1% | 1,430 | $564.00 | |
| 85610 | <1% | 1,659 | $546.99 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,434 | $493.12 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 525 | $389.10 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 284 | $367.15 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 150 | $355.49 |
| 84439 | <1% | 453 | $292.85 | |
| 82607 | <1% | 320 | $285.87 | |
| 81003 | <1% | 3,632 | $197.61 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 26 | $192.37 |
| Q3014 | Telehealth originating site facility fee | <1% | 13 | $177.76 |
| 83880 | <1% | 116 | $155.44 | |
| 86063 | <1% | 129 | $128.02 | |
| 82553 | <1% | 119 | $96.17 | |
| 81025 | <1% | 289 | $87.62 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 205 | $84.82 |
| 83735 | <1% | 1,014 | $77.34 | |
| 83690 | <1% | 628 | $32.90 | |
| 82550 | <1% | 230 | $13.32 | |
| 86706 | <1% | 63 | $10.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 469 | $7.53 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 491 | $0.41 |
| 83605 | 0% | 74 | $0.00 | |
| 87340 | 0% | 40 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 17 | $0.00 |
| 86704 | 0% | 39 | $0.00 | |
| 86701 | 0% | 27 | $0.00 | |
| 86803 | 0% | 39 | $0.00 | |
| 82043 | 0% | 68 | $0.00 | |
| 85651 | 0% | 40 | $0.00 | |
| 85730 | 0% | 17 | $0.00 | |
| 81015 | 0% | 14 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 20 | $0.00 |
| 86592 | 0% | 13 | $0.00 | |
| 82570 | 0% | 74 | $0.00 | |
| 84550 | 0% | 118 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 26 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 42 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 42 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHUMANN, GREGORY (BUSINESS OFFICE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| MT Grant General Hospital | Hawthorne, NV | $1.98M |
| MT. Grant General Hospital | Hawthorne, NV | $29K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.